COLD SPRING HARBOR, NY (GenomeWeb) — Using a CRISPR-Cas9-mediated genome-wide screen, researchers have been able to identify genes linked to skin cancer treatment resistance, according to work presented at the Biology of Genomes conference by Neville Sanjana, a postdoctoral researcher at the Broad Institute.